• About us
• Contact

Advertisement

Organisation › Details

IsoPlexis Corporation

IsoPlexis is a life science technology company building solutions to accelerate the development of curative medicines and personalized therapeutics. Our award-winning single-cell proteomics systems reveal unique biological activity in small subsets of cells, allowing researchers to connect more directly to in-vivo biology and develop more precise and personalized therapies. Our integrated systems – named as a top innovation or design by the Scientist Magazine, Fierce, BIG Innovation and Red Dot, among others – are used globally to advance the field of single-cell biology into new 'omic possibilities as our customers generate solutions to overcome the challenges of complex diseases and therapeutics. Our products have been adopted by researchers around the world, including 15 of the top 15 global pharmaceutical companies and by approximately 45% of comprehensive cancer centers. *

 

	Start	2013-01-01 established
	End	2023-03-20 merged
	Group	Bruker (Group)
	Today	PhenomeX Inc. (CELL)
	Successor	PhenomeX Inc. (CELL)
	Industry	proteomic technology
	Industry 2	single cell analysis
	Region	Branford, CT
	Country	United States (USA)
	Street	35 NE Industrial Road
	City	06405 Branford, CT
		Address record changed: 2021-03-28
Basic data	Employees	D: 101 to 500 (2021-01-07)
		* Document for »About Section«: IsoPlexis. (1/7/21). "Press Release: IsoPlexis Announces $135 Million Financing Led by Perceptive Advisors". Branford, CT.
		Record changed: 2023-08-23

Advertisement

More documents for Bruker (Group)

• [1] Bruker Corporation. (1/7/25). "Press Release: Bruker Corporation to Present at the 43rd Annual J.P. Morgan Healthcare Conference". Billerica, MA....
• [2] Bruker Corporation. (1/7/25). "Press Release: Bruker Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Billerica, MA....
• [3] Bruker Corporation. (12/20/24). "Press Release: Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility". Zürich....
• [4] Ion Opticks Pty Ltd.. (12/5/24). "Press Release: IonOpticks’ Custom Chromatography Column to Become Biognosys’ Standard for High-quality Proteomic Insights". Melbourne....
• [5] Bruker Corporation. (10/2/24). "Press Release: Bruker Acquires Dynamic Biosensors, a Pioneer of Single-Cell Interaction Cytometry Systems for Drug Discovery". Munich....
• [6] Bruker Corporation. (8/23/24). "Press Release: Bruker Corporation to Present at Upcoming Investor Conferences". Billerica, MA....
• [7] Bruker Corporation. (8/7/24). "Press Release: Bruker Announces Strategic Minority Investment in Novalix"....
• [8] Bruker Corporation. (7/2/24). "Press Release: Bruker Announces Successful Installation of a 1.2 GHz NMR at the Leibniz Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin". Berlin....
• [9] Bremen, Senatskanzlei. (5/16/24). "Pressemitteilung: Massenspektrometrie aus Bremen – Bruker Daltonics erweitert Produktion mit zweitem Standort in der Hansestadt". Bremen....
• [10] NanoString Technologies, Inc.. (4/17/24). "Press Release: NanoString Technologies to Be Acquired by Bruker Corporation. Bruker Wins Competitive Auction". Seattle, WA....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2025. Made in Germany.